BREZ
BREZCIK 0002095443
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (WS 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade BREZ commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Breeze Acquisition Corp. II (BREZ) files S-1/A for $125M SPAC IPO of 12.5M units at $10.00 each
5 material changes detected. Sign up free to read the summary.
Latest financial statements
From 10-Q filed Sep 23, 2026 (period ending Mar 31, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statement of Operations (Unaudited)
| Description | Three months ended March 31, 2026 |
|---|---|
| Operating and formation costs | 138,206 |
| Net loss | (138,206) |
| Weighted average shares outstanding, basic and diluted(1) | 4,391,892 |
| Basic and diluted net loss per ordinary share | (0.03) |
Condensed Balance Sheet
| Description | March 31, 2026 (unaudited) | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Prepaid expenses | 37,137 | 39,678 |
| Total current assets | 37,137 | 39,678 |
| Deferred offering costs | 454,063 | 177,490 |
| TOTAL ASSETS | 491,200 | 217,168 |
| LIABILITIES AND SHAREHOLDER’S DEFICIT: | ||
| Current liabilities: | ||
| Promissory note related party | 427,150 | 162,650 |
| Accounts payable | 289,166 | 85,412 |
| Accrued expenses | 14,429 | 70,445 |
| Total Liabilities | 730,745 | 318,507 |
| Commitments and Contingencies (Note 7) | ||
| Shareholder’s Deficit: | ||
| Preference shares, $0.0001 par value; 1,250,000 shares authorized; none issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
| Ordinary shares, $0.0001 par value, 125,000,000 shares authorized, 5,050,676 issued and outstanding at March 31, 2026 and December 31, 2025 (1) | 505 | 505 |
| Additional paid-in capital | 24,495 | 24,495 |
| Accumulated deficit | (264,545) | (126,339) |
| Total Shareholder’s Deficit | (239,545) | (101,339) |
| LIABILITIES AND SHAREHOLDER’S DEFICIT | 491,200 | 217,168 |
Condensed Statement of Cash Flows (Unaudited)
| Description | Three months ended March 31, 2026 |
|---|---|
| Net loss | (138,206) |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | 2,541 |
| Accounts payable | 11,522 |
| Accrued expenses | (9,096) |
| Net cash used in operating activities | (133,239) |
| Cash Flows from Financing Activities: | |
| Proceeds from promissory note related party | 264,500 |
| Payment of deferred offering costs | (131,261) |
| Net cash provided by financing activities | 133,239 |
| Net Change in Cash | — |
| Cash Beginning of period | — |
| Cash End of period | — |
| Supplemental disclosure of non-cash investing and financing activities: | |
| Deferred offering costs included in accounts payable | 192,232 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗